School of Medicine
Showing 1-10 of 67 Results
Robert Michael Fairchild
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Bio Dr. Fairchild specializes in the diagnosis, evaluation and management of rheumatologic diseases. He has a particular interest in musculoskeletal ultrasound and heads the Division of Immunology and Rheumatology's Diagnostic and Interventional Musculoskeletal Ultrasound Clinic. Dr. Fairchild, received his Ph.D. from Georgetown University, and his M.D. from Columbia University College of Physicians and Surgeons. He completed internship and residency in the Department of Medicine at Stanford University. He continued on at Stanford, completing his fellowship in rheumatology and subsequently joined the faculty of the Division of Immunology and Rheumatology. He trained in rheumatologic musculoskeletal ultrasound through the USSONAR program and is certified in this technique through the American College of Rheumatology (RhMSUS certification).
Alice C. Fan
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
Clinical Instructor, Medicine - Vaden Health Center
Bio Diana Farid MD, MPH is a physician, filmmaker and writer. She is a staff physician at the Stanford Vaden Health Center, clinical instructor in the Stanford Department of Medicine, assistant director of Stanford School of Medicine's Program in Bioethics and Film, Medicine and the Muse Program in Medical Humanities and the Arts, Center for Biomedical Ethics. She holds a BA in Peace and Conflict Studies from Berkeley. She was awarded a fellowship by the Maternal and Child Health Bureau, U.S. Department of Health and Human services to obtain a Masters in Public Health and serve as a Child and Family Health Leadership Fellow at UCLA, focusing on community health sciences and health communications. She has provided public health education and health care in rural villages in Honduras, promoted peace in the Ukraine and Malaysia, served at an international school in China, worked at the US Agency for International Development in human rights and has had active roles at both Physicians for Social Responsibility and Physicians for Human Rights. She has cared for patients in a wide range of clinic settings including at the Los Angeles Free Clinic, Kaiser, private and university affiliated practices. She has served as an attending teaching physician to UCLA medical students and internal medicine residents and for two years, served as "Doctoring" course faculty to first year UCLA medical students. As a physician consultant for "The Media Project,” Advocates for Youth, Diana worked with television and film writers and producers to promote adolescent health through entertainment, providing on and off camera expertise on adolescent health issues. As a producer with FiddleHeadFern Productions, she produced her debut feature length documentary film, AMERICAN RHYTHMS (2009) (americanrhythmsmovie.com/), which explores the positive impact of music on health by following a group of 5th grade students at a Los Angeles urban elementary school and their experience of the positive psychological and emotional health effects of a tailored drumming program.
John W. Farquhar, M.D.
Professor of Medicine and of Health Research and Policy, Emeritus
Current Research and Scholarly Interests Chronic disease prevention, epidemiology of chronic diseases, community-based education for disease prevention, global health, politics and public health.
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly Interests My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.
Postdoctoral Research Fellow, Cardiovascular Medicine
Bio My long-term goal is to learn, develop and design frameworks to implement “Precision Medicine” based on the “rare” and “common” genomic variants. Particularly, I am enthusiastic to construct global precision medicine basis to help individuals with diabetes, insulin resistance and cardiovascular comorbidity.
After completing my master’s degree in human genetics, I was attracted by the fact that early onset coronary artery disease (CAD) manifest as a genetic subtype of the common type of CAD. In collaboration with Dr. Arya Mani and Dr. Richard Lifton, experts in Mendelian forms of CAD (Yale University), and Dr. Reza Malekzadeh, a pioneer of cohort studies (Tehran University), I contributed to the genetic analysis of families with early onset CAD and metabolic syndrome. We identified DYRK1B as a causative gene (co-first author; N Engl J Med; 2014).
After completion of Ph.D. I was enthusiastic to be trained deeply on the genetic basis of diabetes and insulin resistance. Navigating through leading institutes, I found Stanford University an ideal place for this training; because here at Stanford Cardiovascular medicine, Dr. Gerald Reaven, a pioneer of insulin resistance, along with Drs. Thomas Quertermous and Joshua Knowles had developed the multicenter cohort for a GWAS of insulin resistance by direct measures of insulin sensitivity including “clamp-based” measures of insulin resistance. This group had just identified and validated a common SNP (rs1208, 803A>G, K268R) in N-acetyltransferase 2 (NAT2) as insulin resistance variant. In this innovative training and career development, I am taking part in defining the role of Nat1 (mouse ortholog of NAT2) in the global and liver specific knockout mice. We have already profiled ‘OMICs changes in the Nat1 global knockout mice with insulin resistance and extensively analyzed the data with promising finding on possible mechanism of mitochondria substrate availability and cholesterol biosynthesis.
During postdoctoral fellowship, I have been involved in the joint project of Stanford-Merck on functional characterization of lipodystrophy-like genes identified through GWAS of glycemic traits (fasting insulin, HDL and WHR adjusted for BMI). This study has opened up new possibility and insight to target peripheral adiposity and insulin resistance. We extensively have been studying one of these promising targets in the transgenic mice and in the data from human cohorts.